Therapeutic advances in amyotrophic lateral sclerosis
Authors:
- J. HugonJHJ. Hugon
- A. DobleADA. Doble
- 1 June 1997
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 18 (6) , 196-203
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Glutamate Antagonists in Amyotrophic Lateral SclerosisCNS Drugs, 1996
- Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortexAnnals of Neurology, 1996
- Peroxynitrite Inhibits Glutamate Transporter SubtypesJournal of Biological Chemistry, 1996
- Amyotrophic Lateral SclerosisDrugs, 1996
- Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosisNeuroscience Letters, 1995
- High‐dose dextromethorphan in amyotrophic lateral sclerosis: Phase I safety and pharmacokinetic studiesAnnals of Neurology, 1994
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiationAnnals of Neurology, 1994
- Parvalbumin and calbindin D‐28k in the human motor system and in motor neuron diseaseNeuropathology and Applied Neurobiology, 1993
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993